中国药物警戒 ›› 2023, Vol. 20 ›› Issue (7): 735-741.
DOI: 10.19803/j.1672-8629.20230273

• 中药及其活性成分抗肿瘤作用研究专栏 • 上一篇    下一篇

基于EGFR的抗肺腺癌中药筛选及其体外作用研究

余悦华, 赵岩, 卢天公, 孙震晓*   

  1. 北京中医药大学生命科学学院,北京 102488
  • 收稿日期:2023-05-04 出版日期:2023-07-15 发布日期:2023-07-14
  • 通讯作者: *孙震晓,女,博士,教授,中药分子药理学与毒理学。E-mail:sunzx@bucm.edu.cn
  • 作者简介:余悦华,女,硕士,抗肿瘤分子细胞药理学。为并列第一作者。
  • 基金资助:
    国家自然科学基金资助项目(81473418、821044 60); 北京中医药大学“揭榜挂帅”项目中药复方抗肿瘤药效机制及转化应用研究(2022-JYB-JBZR-022、2022-JYB-JBZR-023、2022-2025); 北京中医药大学纵向科研发展基金项目(2170072120008)

Screening and in vitro study of traditional Chinese medicines against lung adenocarcinoma based on EGFR

YU Yuehua, ZHAO Yan, LU Tiangong, SUN Zhenxiao*   

  1. School of Life Sciences, Beijing University of Chinese Medicine, Beijing 102488, China
  • Received:2023-05-04 Online:2023-07-15 Published:2023-07-14

摘要: 目的 基于肺腺癌特异性靶点表皮生长因子受体(epidermal growth factor receptor,EGFR),利用TCMSP数据库及分子对接技术虚拟筛选出可能具有抗肺腺癌作用的中药或中药部位,并探究其体外抗肺腺癌作用及机制。方法 将TCMSP数据库中经过类药和吸收-分布-代谢-排泄(absorption-distribution-metabolism-excretion,ADME)筛选的中药小分子化合物与EGFRL858R/T790M/C797S突变体进行分子对接,虚拟筛选出可能具有抗肺腺癌作用的中药或中药部位;MTT法进行初步的抗肺腺癌活性验证和体外筛选,根据对人肺腺癌细胞NCI-H1975与人肺成纤维细胞HPF的区别细胞毒作用进一步筛选出潜在的抗肺腺癌中药或中药部位;流式细胞术检测潜在抗肺腺癌中药或中药部位对NCI-H1975细胞凋亡及线粒体膜电位的影响;Western印迹法检测连翘提取物和知母总皂苷对于EGFR及其下游靶点AKT的蛋白表达及磷酸化的影响。结果 虚拟筛选出候选抗肺腺癌中药8味(肉豆蔻、连翘、百部、半边莲、郁金、荜茇、玉竹、知母)和中药部位3个(百部生物碱、知母总皂苷、绞股蓝总皂苷);体外实验研究发现,知母、连翘提取物及百部生物碱、知母总皂苷对人肺腺癌细胞NCI-H1975细胞毒作用较强,作用呈一定时间和剂量依赖性;同等剂量下连翘提取物和知母总皂苷对HPF的细胞毒作用较弱,对人肺腺癌和肺成纤维细胞具有一定区别作用,进一步研究发现,其能诱导NCI-H1975线粒体膜电位下降及细胞凋亡并抑制EGFR-PI3K/AKT信号通路的活化。结论 基于肺腺癌特异靶点,利用中药及中药成分数据库通过分子对接等手段可以虚拟筛选抗肺腺癌中药或中药部位,通过体外实验进一步筛选对肺腺癌及肺正常细胞有区别作用的中药或中药部位,并揭示其作用机制。

关键词: 肺腺癌, 表皮生长因子受体, 分子对接, 连翘, 知母总皂苷, 线粒体膜电位, 细胞凋亡

Abstract: Objective Using molecular docking virtual screening and TCMSP to screen out traditional Chinese medicines and sections that may have anti-lung adenocarcinoma effects, and studying it’s effects against lung adenocarcinoma in vitro. Methods Small molecule compounds of TCSMP database were screened based on Lipinski’s rule of five and ADME were docked with EGFRL858R/T790M/C797S to obtain candidate traditional Chinese medicines or sections against lung adenocarcinoma through the frequency of docking molecules; preliminary validation of anti-lung adenocarcinoma activity and in vitro screening of extract of candidate traditional Chinese medicines or sections against lung adenocarcinoma using MTT method. Further optimization of candidate traditional Chinese medicines or sections against lung adenocarcinoma through differential killing effects of drugs on human lung adenocarcinoma cells NCI-H1975 and human lung fibroblast cells HPF; flow cytometry was used to detect the effects of drugs on apoptosis and mitochondrial membrane potential of NCI-H1975; Western blot was used to detect the effects of drugs on protein expression and phosphorylation of EGFR and its downstream target AKT. Results Through molecular docking results and literature research to screen 8 candidate traditional Chinese medicines (Myristicae Semen, Forsythiae Fructus, Stemonae Radix, Lobeliae Chinensis herba, Curcumae Radix, Piperis Longi Fructus, Polygonati Odorati Rhizoma and Anemarrhenae Rhizoma) and 3 parts of traditional Chinese medicine (total alkaloids of Radix Stemonae, total saponins of Anemarrhenae Rhizoma and total saponins of Gynostemma Pentaphyllum); in vitro experiment studies found that extract of Anemarrhenae Rhizoma and Forsythiae Fructus, total alkaloids of Radix Stemonae and total saponins of Anemarrhenae Rhizoma had strong killing effects on NCI-H1975, with a certain time and dose dependent effect. At the same dose, extract of Forsythiae Fructus and total saponins of Anemarrhenae Rhizoma had weak killing effects on HPF. Further research found that they can decrease mitochondrial membrane potential, induce apoptosis and inhibit the activation of the EGFR-PI3K/AKT signaling pathway of NCI-H1975. Conclusion Based on the specific target of lung adenocarcinoma, the database of traditional Chinese medicines and components can be used to virtually screen anti-lung adenocarcinoma traditional Chinese medicines or sections through molecular docking and other ways, and in vitro experiments were used to detect differential effects of traditional Chinese medicines or sections against lung adenocarcinoma on lung adenocarcinoma cells and normal lung cells, further optimize the screening results, and reveal it’s anti-lung adenocarcinoma mechanism.

Key words: lung adenocarcinoma, EGFR, molecular docking, Forsythiae Fructus, total saponins of Anemarrhenae Rhizoma, mitochondrial membrane potential, cell apoptosis

中图分类号: